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Summary
Translational control is a key genetic regulatory
mechanism implicated in regulation of cell and organ-
ismal growth and early embryonic development. Initi-
ation at the mRNA 5 cap structure recognition step
is frequently targeted by translational control mecha-
nisms. In the Drosophila embryo, cap-dependent
translation of the uniformly distributed caudal (cad)
mRNA is inhibited in the anterior by Bicoid (Bcd) to
create an asymmetric distribution of Cad protein.
Here, we show that d4EHP, an eIF4E-related cap bind-
ing protein, specifically interacts with Bcd to sup-
press cad translation. Translational inhibition de-
pends on the Bcd binding region (BBR) present in the
cad 3 untranslated region. Thus, simultaneous in-
teractions of d4EHP with the cap structure and of Bcd
with BBR renders cad mRNA translationally inactive.
This example of cap-dependent translational control
that is not mediated by canonical eIF4E defines a new
paradigm for translational inhibition involving tether-
ing of the mRNA 5 and 3 ends.
Introduction
In the absence of transcription during early embryogen-
esis, many genes are regulated at the level of transla-
tion (Wickens et al., 2000). Translation rates are often
controlled at the initiation phase, a multistep process
involving the recruitment of the 40S small ribosomal
subunit to the 5# end of an mRNA, which culminates in
the positioning of the ribosome at the initiation codon
(Hershey and Merrick, 2000; Poulin and Sonenberg,
2003). The mRNA 5# cap structure (m7GpppN, where N
is any nucleotide) (Shatkin, 1976) facilitates ribosome
binding to the mRNA via an interaction with the cap
binding complex, eukaryotic initiation factor (eIF) 4F.*Correspondence: fpoulin@berkeley.edu (F.P.); nahum.sonenberg@
mcgill.ca (N.S.)
3 These authors contributed equally to this work.
4 Present address: Department of Integrative Biology, University of
California, Berkeley, Berkeley, California 94720.eIF4F is composed of three subunits: eIF4E, eIF4A,
and eIF4G. Simultaneous interaction of eIF4G with
eIF4E and poly(A) binding protein (PABP) brings about
mRNA circularization and promotes the recruitment of
the 40S ribosomal subunit (Gebauer and Hentze, 2004;
Kahvejian et al., 2005; Sachs, 2000). Because of their
key roles, eIF4E and PABP have emerged as major
targets of translational regulatory mechanisms. Several
mechanisms of modulating their activity have now been
described. eIF4E binding proteins (4E-BPs) inhibit
general cap-dependent translation by sequestering
eIF4E from the eIF4F complex (Gingras et al., 1999;
Raught et al., 2000). An mRNA-specific mechanism of
cap-dependent inhibition involves proteins such as
Cup (Nakamura et al., 2004; Nelson et al., 2004; Wilhelm
et al., 2003) and Maskin (Stebbins-Boaz et al., 1999),
which interact simultaneously with eIF4E and, either di-
rectly or indirectly, with the 3# end of an mRNA (Richter
and Sonenberg, 2005). Another mechanism involves
PABP-interacting protein 2 (Paip2), which binds to
PABP and displaces it from the poly(A) tail, effectively
inhibiting translation by interdicting mRNA circulariza-
tion (Kahvejian et al., 2005; Khaleghpour et al., 2001).
Embryonic pattern is established in Drosophila by
several proteins that are targeted to defined regions of
the cytoplasm, and translational regulation plays a
central role in their localization (Johnstone and Lasko,
2001; Kuersten and Goodwin, 2003; St Johnston and
Nusslein-Volhard, 1992; Wickens et al., 2000). For ex-
ample, a posterior-to-anterior gradient of Caudal (Cad)
protein is established in early embryogenesis from uni-
formly distributed maternal cad mRNA, and this gradi-
ent is essential for posterior patterning. Establishment
of the Cad gradient requires Bicoid (Bcd), which medi-
ates cap-dependent translational repression of cad
mRNA dependent on the Bcd binding region (BBR), an
element in its 3# untranslated region (UTR) (Chan and
Struhl, 1997; Dubnau and Struhl, 1996; Niessing et al.,
1999; Rivera-Pomar et al., 1996). It has been proposed
that Bcd blocks cad mRNA translation by interacting
with eIF4E to prevent eIF4F complex formation (Nies-
sing et al., 2002).
An eIF4E-related protein called human eIF4E-Homol-
ogous protein (h4EHP) was previously described (Rom
et al., 1998). However, the function, if any, of 4EHP in
translation has been elusive, since it does not interact
with eIF4G (Hernandez et al., 2005; Rom et al., 1998)
and thus cannot function in ribosome recruitment.
Here, we show that the Drosophila 4EHP homolog
(d4EHP) interacts with Bcd to inhibit the anterior
translation of maternal cad mRNA. Translational regula-
tion of cad mRNA thus involves a unique translational
inhibitory mechanism.
Results
d4EHP Is a Cap Binding Protein
4EHP is evolutionarily conserved in metazoans and
plants (Figure 1A). The d4EHP gene (GenBank: NM_
176552; Gadfly: CG33100) encodes a 223 amino acid
Cell
412Figure 1. 4EHP Is an Evolutionarily Conserved Cap Binding Protein
(A–C) Identical amino acids are highlighted in red and conserved ones in yellow. Residues that function in cap binding (Marcotrigiano et al.,
1997; Matsuo et al., 1997) are highlighted in green. Conserved residues that form contacts between eIF4E and eIF4G (Gross et al., 2003;
Marcotrigiano et al., 1999) are highlighted in blue. Stars indicate the position of the eight tryptophan residues conserved in eIF4E through
evolution; Trp43 and Trp56 are replaced by tyrosines in 4EHP (black stars). The eIF4E residue Trp73, critical for eIF4G and 4E-BP interaction
in the mouse and by inference in flies, is indicated by a red star.
(A) Sequence alignment of 4EHP from D. melanogaster (d4EHP), human (h4EHP), mouse (m4EHP), X. laevis (x4EHP), C. elegans (IFE-4), and
A. thaliana (nCBP).
(B) Amino acid sequence of mouse eIF4E (meIF4E).
(C) d4EHP is similar to deIF4E. Sequence alignment of D. melanogaster eIF4EI (deIF4EI) and d4EHP.
(D) d4EHP antiserum detects recombinant d4EHP. Recombinant His-tagged d4EHP (lane 1) is detected in a Western blot with a d4EHP
antiserum (lane 3) but not with preimmune serum (lane 2).
(E) d4EHP antiserum immunoprecipitates d4EHP from cell extracts. HA-tagged d4EHP was transfected in 293 cells (lane 1) and immunopreci-
pitated with an anti-HA antibody (lane 2), preimmune serum (lane 3), or d4EHP antiserum (lane 4).
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413ants. Immunoprecipitation with an anti-FLAG antibodymental Figure S2).
(F) d4EHP is a cap binding protein. Cap binding proteins were affinity purified from Drosophila S2 cell extracts using m7GTP-Sepharose (lanes
2 and 4). The eluates were analyzed by Western blotting for the presence of deIF4E or d4EHP. GDP-Sepharose affinity purification was used
as a negative control (lanes 1 and 3).
(G) Trp114 is critical for the d4EHP:Cap interaction. 293 cell extracts (top) containing transfected HA-tagged d4EHP (lane 1), d4EHPW85F (lane
2), and d4EHPW114A (lane 3) were incubated with m7GTP-Sepharose, and the eluate was analyzed by Western blotting (bottom).protein with a predicted molecular mass of 26 kDa.
Most amino acids implicated in eIF4E binding to the
cap structure (Marcotrigiano et al., 1997; Matsuo et al.,
1997) are conserved in d4EHP (Figures 1A–1C), al-
though two of eight conserved tryptophan residues in
eIF4E are replaced by tyrosines in 4EHP (Figures 1A–
1C). While one of these residues, Trp56 in eIF4E (Tyr68
in d4EHP; Figures 1A and 1B), directly interacts with
the ring structure of the m7G cap (Marcotrigiano et al.,
1997; Matsuo et al., 1997), it is replaced with other aro-
matic amino acids in disparate cap binding proteins,
such as VP39 and CBP20, indicating that the aromatic
ring is the important chemical moiety for cap interac-
tion (Calero et al., 2002; Hodel et al., 1997; Mazza et
al., 2001).
An antiserum against GST-d4EHP fusion protein, which
recognizes recombinant His-d4EHP by immunoblot-
ting, was raised (Figure 1D). The specificity of the anti-
serum was established by immunoprecipitation of HA-
tagged d4EHP from transfected 293 cells (Figure 1E).
Like deIF4E, d4EHP binds to m7GTP-Sepharose, but
not to GDP-Sepharose (Figure 1F). eIF4E and d4EHP
share a common cap binding mechanism, since muta-
tion of the d4EHP equivalent of murine eIF4E Trp102
(Trp114 in d4EHP) significantly reduced the ability of
d4EHP to bind to the cap structure (Figure 1G). Muta-
tion of d4EHP Trp85, a residue to be discussed later in
this report, does not affect cap binding (Figure 1G).
d4EHP Genetically Interacts with cad
d4EHP is uniformly distributed in early Drosophila em-
bryos (see Supplemental Figure S1A available with this
article online). To investigate its biological function, we
produced mutants by imprecise excision of a P element
inserted within the first exon of d4EHP (BG017013; Fig-
ure 2A; Bellen et al., 2004). One of several deletion lines
we obtained, which is referred to as d4EHPCP53, carries
an excision of w2.1 kb that deletes all of exon I, includ-
ing the translation start site, and part of intron I (Figure
2A). The resulting mutant is hypomorphic, as immu-
noblotting (Figure 2B) and immunostaining (Supple-
mental Figure S1B) detected the presence of small
amounts of d4EHP in mutant embryo (7%, relative to
wild-type; Figure 2B). This is most probably due to the
presence of an in-frame AUG (AUG*) at the end of
the first intron (Figure 2A) that remains present in the
d4EHPCP53 deletion. Consistent with this, a transcript
that contains part of intron I and the AUG* is detected,
albeit at reduced levels (w5%), in the d4EHPCP53 mu-
tant line (Figure 2C, compare lanes 1 and 4). The pre-
dicted mutant d4EHP lacks the first 12 amino acids of
the wild-type protein, which are replaced by six new
amino acids (Figure 2D). Expression of syntaxin 1A
(syx1A), located in the second intron of d4EHP (Figure
2A), is not affected by the d4EHPCP53 mutation (Supple-The d4EHPCP53 mutant is homozygous viable and
does not display any obvious zygotic phenotype. How-
ever, embryos produced by homozygous d4EHPCP53 fe-
males have a substantially reduced hatching frequency
(52%) compared to wild-type flies (93%). Flies that do
hatch have no conspicuous phenotypic defects, even
when genetically homozygous themselves. The em-
bryos that do not hatch exhibit patterning defects
mostly affecting anterior segmentation (Supplemental
Figure S3).
Because of these patterning defects, we investigated
whether d4EHP activity is involved in translational regu-
lation of maternal cad mRNA. Remarkably, in contrast
to wild-type embryos (Figure 2E), those from mothers
homozygous for d4EHPCP53 (subsequently termed
d4EHPCP53 mutant embryos) show Cad ectopically ex-
pressed at the anterior end (Figure 2H; note however
that the anterior expression of Cad is weaker than in
the posterior, most likely because of the residual
d4EHP). The expression of Cad in the anterior is not
due to an alteration in the Bcd gradient, since Bcd-
dependent zygotic hunchback (hb) mRNA expression
(Tautz, 1988) is unaffected in d4EHPCP53 mutant em-
bryos (Figure 2I). In addition, cad mRNA expression
levels (Supplemental Figure S4A) and localization (Fig-
ure 2J) are unaltered in d4EHPCP53 mutant embryos.
These results demonstrate that d4EHP activity is re-
quired to repress Cad expression at the anterior of the
embryo.
d4EHP Interacts Biochemically
with the Anterior Determinant Bcd
Next, we investigated whether d4EHP and Bcd interact
in vivo. Extracts prepared from 0–2 hr wild-type em-
bryos were treated with RNase and used to examine
the interaction between Bcd and deIF4E or d4EHP (Fig-
ure 3A). Preimmune sera failed to precipitate deIF4E
or d4EHP. Anti-deIF4E immunoprecipitated deIF4E, but
not Bcd. In contrast, anti-d4EHP readily coimmuno-
precipitated endogenous Bcd, thus demonstrating that
Bcd exhibits much stronger affinity for d4EHP than for
deIF4E. These results are at variance with a paper pub-
lished by Niessing et al. (2002), which concluded that
an interaction between deIF4E and Bcd exists. This
discrepancy will be addressed in the Discussion.
Three alternatively spliced forms of bcd mRNA pro-
duce different variants of Bcd protein (Driever and
Nusslein-Volhard, 1988b). Only two of these variants,
Bcd1-489 and Bcd1-494, contain the homeobox domain
that is critical for inhibiting anterior cad translation
(Dubnau and Struhl, 1996; Rivera-Pomar et al., 1996).
To determine whether Bcd1-489 and Bcd1-494 differ in
their ability to interact with d4EHP, HA-tagged deIF4EI
(as a negative control) or d4EHP was transfected into
293 cells with each of the two FLAG-tagged Bcd vari-
Cell
414Figure 2. Characterization of d4EHPCP53 Mutant
(A) Schematic representation of the d4EHP gene. The d4EHP gene spans w45 Kbp and comprises four exons (boxes) and three introns (solid
lines). Syntaxin 1A (Syx1A) is nested in the second intron of d4EHP (yellow box) and is transcribed in the same orientation. P element
(BG01713) is inserted in exon I of the gene (d4EHP panel). AUG* in d4EHPCP53 is an alternative translation start site that becomes active upon
excision of exon I and part of intron I (d4EHPCP53 panel). Location of RT-PCR primers are indicated by blue arrows. The number of amino
acids encoded by the mRNA is indicated on the right.
(B) Reduced d4EHP expression in the d4EHPCP53 mutant. Wild-type (OreR) and d4EHPCP53 embryo extracts were analyzed by Western
blotting using anti-d4EHP and anti-α-tubulin as a loading control.
(C) RT-PCR analysis of total RNA using primers specific for the wild-type d4EHP (Fwd A in exon I) or d4EHPCP53 mutant (Fwd B in intron I).
Actin mRNA is used as a loading control.
(D) Translation from the wild-type and mutant genes is predicted to produce different N-terminal ends.
(E–G) OreR embryo displays wild-type Cad gradient (E), zygotic hb transcription (F), and cad distribution (G).
(H–J) 0–2 hr d4EHPCP53 mutant embryo show ectopic Cad expression at the anterior end (H), yet has normal zygotic hb activation (I) and cad
localization (J). To maximize signal-to-background ratio, sagittal sections of embryos are used to display Cad gradients; hence the absence
of surface nuclei that are evident in embryo images presented in Figures 4 and 6. Orientation of embryos is anterior left and dorsal up.demonstrates that neither one of the Bcd spliced vari- q
pants interacts detectably with deIF4EI, while both ex-
hibit a comparable interaction with d4EHP (Figure 3B).
tWe therefore used the Bcd1-494 isoform for all subse-uent experiments and will refer to it as Bcd for sim-
licity.
The similarity between 4EHP and eIF4E is not limited
o the amino acids that participate in binding the 5#
d4EHP, a Cap Binding Inhibitor of Translation
415Figure 3. d4EHP Interacts with Bcd In Vivo
and In Vitro
(A) d4EHP interaction with endogenous Bcd.
0–2 hr OreR embryo extract (lane 1) was im-
munoprecipitated (IP) using preimmune (lane
2), anti-deIF4E (lane 3), or anti-d4EHP (lane
4). Immunoprecipitated proteins were ana-
lyzed by Western blotting for the presence
of Bcd (top panel), deIF4E (second panel),
and d4EHP (third panel). The presence of en-
dogenous cad mRNA in the extracts was an-
alyzed by RT-PCR (bottom panel).
(B) d4EHP interacts with two alternatively
spliced variants of Bcd. FLAG-tagged Bcd1-489
and Bcd1-494 were transfected in 293 cells
together with HA-tagged deIF4EI or d4EHP.
Extracts were immunoprecipitated (IP) with
anti-FLAG and analyzed by Western blotting.
(C) Bcd interaction requires a conserved
tryptophan residue (W85) in d4EHP. FLAG-
tagged Bcd was transfected in 293 cells with
HA-tagged deIF4EI (lane 1), d4EHP (lane 2),
d4EHPW85F (lane 3), and d4EHPW114A (lane
4). Extracts (top panels) were immunopreci-
pitated (IP) with anti-FLAG and analyzed by
Western blotting (bottom panels).cap structure. Also highly conserved between the two
proteins are several residues that play a role in the in-
teraction between eIF4E and eIF4G or 4E-BP (Figures
1B and 1C; Gross et al., 2003; Marcotrigiano et al.,
1999). In heIF4E, Trp73 directly contacts eIF4G and 4E-
BP (Marcotrigiano et al., 1997; Marcotrigiano et al.,
1999; Pyronnet et al., 1999). Despite the fact that the
equivalent of Trp73 is conserved in all 4EHPs (Trp85 in
d4EHP), 4EHP does not interact with eIF4G in mam-
mals (Rom et al., 1998; Tee et al., 2004) and in Drosoph-ila (data not shown; Hernandez et al., 2005). It was
therefore pertinent to determine whether Trp85 is re-
quired for d4EHP interaction with Bcd. To this end, HA-
tagged deIF4EI, d4EHP, d4EHPW85F, and d4EHPW114A
mutants were transfected in 293 cells along with FLAG-
tagged Bcd. FLAG-Bcd coimmunoprecipitated wild-
type HA-d4EHP, but not HA-deIF4EI (Figure 3C). Muta-
tion of Trp85 in d4EHP to Phe abrogated Bcd binding,
while the W114A mutation, which affects cap binding,
did not (Figure 3C). Taken together, these results de-
Cell
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occurs on the convex dorsal surface of d4EHP, as de-
termined by the predicted position of Trp85 on a homol-
ogy model (data not shown; Rom et al., 1998). This em-
ulates the mechanism used by eIF4Gs/4E-BPs for their
interaction with eIF4E (Gross et al., 2003; Marcotrigiano
et al., 1999).
d4EHP Interacts with Both Bcd and cad mRNA 5
Cap Structure to Inhibit Cad Expression
To show that the Bcd and cap binding abilities of
d4EHP are required for the translational inhibition of
cad mRNA, we generated transgenic fly lines that over-
express wild-type or mutant forms of d4EHP (Figure 4A)
and assessed their ability to rescue the d4EHPCP53 mu-
tation. Three independent insertion lines were exam-
ined for each construct. For simplicity, embryos will be
referred to by their maternal genotype. In contrast to
wild-type embryos (Figure 4B), d4EHPCP53 embryos
show Cad expression domains extending farther to-
ward the anterior (Figure 4C). While transgene-derived
expression of wild-type d4EHP (d4EHPWT) rescued this
effect (Figure 4D), the Bcd and cap binding mutants of
d4EHP (d4EHPW85F and d4EHPW114A, respectively)
failed to establish a wild-type Cad gradient (Figures 4E
and 4F), even though cad mRNA expression levels
(Supplemental Figure S4A) and distribution (Supple-
mental Figure S4C–S4E) are indistinguishable from
wild-type. Thus, the ability of d4EHP to bind to both
Bcd and the cap structure is critical for the efficient
inhibition of anterior cad mRNA translation.
Delineation of the Bcd d4EHP Binding Motif
A Bcd mutant (Y68A/L73R) that fails to inhibit anterior
cad mRNA translation was previously described (Nies-
sing et al., 2002). The two residues that were changed
simultaneously in this mutant affect the canonical
YxxxxLf eIF4E binding motif (Mader et al., 1995; Figure
5A) and are critical for binding to eIF4E in all eIF4E
binding proteins. We investigated whether the canoni-
cal eIF4E binding site of Bcd was required for binding
to d4EHP. Point mutations were engineered to replace
four amino acids that are near to, or fall within, the
eIF4E binding site. As noted above, two of the single
point mutations, Y68A and L73R, replace amino acids
Fthat are critical for the interaction between eIF4E and
cits partners. Two other mutations, Y66A and Y72A,
(change residues at position −2 and +4, relative to the
bconserved Tyr68 (Figure 5B).
(
Transgenic fly lines carrying targeted bcd mutations (
were crossed into a bcd null background (bcdE1), and t
(embryos from females expressing Bcd only from the
mtransgenes were obtained. RNase-treated embryo ex-
(tracts were then immunoprecipitated with deIF4E- or
(d4EHP-specific antibodies, and the immunopreci-
e
pitates were analyzed by immunoblotting for the b
presence of Bcd (Figure 5C). Consistent with our earlier
results, endogenous Bcd coimmunoprecipitates with
d4EHP, but not with deIF4E. Surprisingly, however, the b
tY68A mutation failed to affect the interaction of Bcd
with d4EHP, whereas the Y66A mutation, which changes w
wa residue outside of the canonical consensus eIF4Eigure 4. d4EHP Interaction with Bcd and the Cap Structure Is Cru-
ial for cad mRNA Translation Inhibition
A) Western blot analysis of d4EHP expression in transgenic em-
ryos (top). Anti-α-tubulin was used as a loading control (bottom).
B) OreR embryos display wild-type Cad gradient.
C) d4EHPCP53 mutant embryo display ectopic Cad expression at
he anterior end.
D) Expression of a d4EHPWT transgene rescues the d4EHPCP53
utant phenotype.
E and F) Embryos from transgenic females expressing d4EHPW85F
E) and d4EHPW114A (F) in the d4EHPCP53 mutant background show
ctopic expression of Cad at the anterior end. Orientation of em-
ryos is anterior left and dorsal up.inding motif, abrogated the interaction. d4EHP:Bcd in-
eraction was also abolished by the L73R mutation, but
as not affected by the Y72A mutation. Consequently,
e conclude that Bcd interaction with d4EHP, unlike
d4EHP, a Cap Binding Inhibitor of Translation
417Figure 5. Bcd Contains a d4EHP Binding
Motif
(A) Alignment of eIF4E binding motifs from
mammalian eIF4GI and 4E-BPs, Drosophila
eIF4G (deIF4G), and Cup, with Bcd amino
acids 65 to 77. f denotes any hydrophobic
amino acid and X any amino acid.
(B) Schematic depiction of Bcd showing mu-
tations in the putative d4EHP binding motif.
(C) In vivo interaction of Bcd mutants with
d4EHP. 0–2 hr embryo extracts from females
homozygous for the listed genotypes were
immunoprecipitated (IP) with anti-deIF4E
(lane 1) or anti-d4EHP (lanes 2–6). Eluted pro-
teins were analyzed for the presence of Bcd,
deIF4E, and d4EHP by Western blotting.that of eIF4G or 4E-BP binding to eIF4E, requires
a sequence motif that is distinct from the canonical
YxxxxLf eIF4E-recognition motif.
The d4EHP:Bcd Interaction Is Required
for Embryonic Patterning and Development
We investigated the effects of these targeted bcd mu-
tants on embryonic development. As previously de-
scribed, OreR embryos (0–2 hr) show an anterior-to-
posterior Cad gradient (Figure 6A) and normal cuticle
segmentation pattern (Figure 6B), while in bcdE1 em-
bryos, Cad is evenly distributed throughout the embryo
(Figure 6C) and a bcd mutant cuticle pattern develops
(Figure 6D; Driever and Nusslein-Volhard, 1988a). Trans-
gene-derived expression of wild-type bcd (bcdWT) res-
cued all mutant phenotypes associated with bcdE1
(Figures 6E and 6F). Embryos expressing forms of Bcd
unaffected for d4EHP binding (bcdY68A or bcdY72A) ex-hibited both a normal Cad gradient (Figures 6I and 6K)
and normal cuticle pattern (Figures 6J and 6L). In con-
trast, bcdY66A and bcdL73R mutant embryos exhibit de-
fects in anterior patterning (Figures 6H and 6N) and do
not establish a Cad gradient (Figures 6G and 6M). Bcd-
dependent zygotic hb expression is normal in all mu-
tant transgenic lines (data not shown; Niessing et al.,
2002), demonstrating that the mutations we examined
specifically affect the d4EHP interaction. Also, cad
mRNA expression levels (Supplemental Figure S4A)
and localization are normal in all the mutant embryos
(Supplemental Figures S4F–S4K). Transgene-depen-
dent Bcd expression levels were similar in all mutant
transgenic lines (Figure 6O).
Next, we examined whether disruption of the Cad
gradient through abrogation of the d4EHP:Bcd interac-
tion affects hatching and development of bcd mutant
embryos. OreR control embryos showed a 94% hatch-
Cell
418Figure 6. Functional Analysis of Mutant Bcd
in Transgenic Drosophila Embryos
(A and B) OreR embryos display wild-type
Cad gradient (A) and cuticle pattern (B).
(C and D) Embryos derived from homozy-
gous bcd E1 females fail to repress anterior
cad mRNA translation (C) and show a bcd
mutant cuticle phenotype (D).
(E and F) Transgenic embryos derived from
females expressing bcdWT rescues the mu-
tant Cad gradient (E) and cuticle pattern (F).
(G and H) Embryos derived from females ex-
pressing the mutant bcd Y66A gene fail to re-
press cad mRNA translation (G) and develop
seemingly normal larval segmentation with
improperly assembled head elements (H).
(I and J) Embryos derived from females ex-
pressing the mutant bcd Y68A gene demon-
strate wild-type cad mRNA translation (I) and
have normal cuticle pattern (J).
(K and L) Embryos derived from females ex-
pressing the mutant bcd Y72A gene demon-
strate wild-type Cad gradient (K) and have
normal cuticle pattern (L).
(M and N) Embryos derived from females ex-
pressing the mutant bcd L73R gene fail to re-
press cad mRNA translation (M) and develop
seemingly normal larval segmentation with
improperly assembled head elements (N).
Orientation of embryos is anterior left and
dorsal up.
(O) Western blot analysis of embryo extracts
using monoclonal anti-Bcd or anti-α-tubulin
as a loading control.ing frequency, and all negative-control bcdE1 mutant T
fembryos failed to hatch (Supplemental Table S1). Ex-
pression of bcdWT, bcdY68A, and bcdY72A rescued the T
qability of bcdE1 embryos to hatch (Supplemental Table
S1) and to give rise to adult flies. However, the two mu- t
qtations that abrogate the Bcd:d4EHP interaction,
bcdY66A and bcdL73R, caused a substantial decrease in v
ithe number of hatching embryos (Supplemental Table
S1). Moreover, at 25°C, most of the hatched bcdY66A t
(and bcdL73R mutant larvae failed to develop into adults.
Taken together, our data demonstrate a critical require- t
cment of the d4EHP:Bcd interaction in Drosophila devel-
opment. (he Interaction of Bcd and d4EHP Is Required
or Translation Inhibition
o demonstrate that the d4EHP:Bcd interaction is re-
uired for the BBR-mediated inhibition of cad transla-
ion, capped reporter mRNAs containing BBR se-
uences in their 3# UTR were used as a template for in
itro translation reactions. The BBR was inserted either
n the sense or antisense orientation in the 3# UTR of
he Renilla reniformis Luciferase (rLuc) reporter mRNA
Figure 7A). Mouse Krebs-2 cell-free translation ex-
racts were used for the assay because they are more
ap dependent than the reticulocyte lysate system
Svitkin et al., 2001) and because they do not contain
d4EHP, a Cap Binding Inhibitor of Translation
419Figure 7. Bcd Specifically Represses Translation in the Presence
of d4EHP
(A) The Bcd binding region (BBR) from the 3# UTR of cad mRNA
was inserted into the 3# UTR of Renilla reniformis luciferase
(rLuc) mRNA, either in the sense (BBRsense) or the antisense
(BBRantisense) orientation.
(B and C) In vitro translation of BBRsense and BBRantisense reporters.
In vitro translation of the BBRsense (B) and the BBRantisense (C) re-
porter mRNAs (lane 1) was performed in the presence of deIF4EI
and wild-type Bcd (lane 2), d4EHP and wild-type Bcd (lane 3),
d4EHP and Bcd Y66A (lane 4), deIF4EI (lane 5), d4EHP (lane 6),
and wild-type Bcd (lane 7). Stability of the reporter mRNAs were
determined by Northern blotting (bottom panels). Data are pre-
sented as mean ± standard deviation from three independent ex-
periments. The value obtained for vector alone was set as 100%.
*p = 0.0004. Statistical analysis was performed with a two-tailed
paired t test.endogenous Bcd. deIF4EI, d4EHP, and Bcd were syn-
thesized in vitro by incubating the translation extract
with their corresponding mRNAs for a period of 1 hr.
Following this preincubation period, the extract was
programmed with the reporter mRNA and incubated for
an additional hour, and rLuc activity was then measured
(Figures 7B and 7C). We first determined whether Bcd
or d4EHP individually affect the translation of the
BBRsense and the BBRantisense reporter. No significant
effect of d4EHP or Bcd was detected. However, addi-
tion of Bcd and d4EHP in combination caused a re-
duction of w60% in translation of the rLuc mRNA
containing the BBRsense sequence. In contrast, the
combination of Bcd and deIF4EI failed to inhibit transla-
tion. The effect of adding Bcd and d4EHP was depen-
dent on their ability to interact, since the BcdY66A mu-
tant failed to inhibit translation. The inhibition by d4EHP
and Bcd was also dependent on the interaction of Bcd
with mRNA, because a reporter mRNA with an inverted
BBR sequence was not regulated by d4EHP:Bcd-com-
plex. Northern blotting analysis shows that the stability
of the reporter mRNA in the translation extract was not
affected by the expression of d4EHP or Bcd (Figures
7B and 7C, bottom panels).
Discussion
cad Translation Is Repressed by a Novel d4EHP-
Dependent Mechanism, Not by Sequestering eIF4E
We describe here a new mode of mRNA-specific trans-
lational inhibition, which acts by tethering the mRNA 5#
and 3# end via d4EHP, an eIF4E-related protein, and
Bcd. d4EHP binds to the cad mRNA 5# cap structure,
while Bcd binds to BBR in its 3# UTR. The interaction
between d4EHP and Bcd is mediated through a se-
quence motif in Bcd that resembles, but is distinct
from, the consensus eIF4E binding domain present in
classical eIF4E binding proteins such as 4E-BPs and
eIF4G. Inhibition of cad mRNA translation by the
d4EHP:Bcd complex demonstrates for the first time the
involvement of a cellular cap binding protein other than
eIF4E in cap-dependent translational control. Further-
more, it provides a new molecular mechanism govern-
ing the formation of morphogenetic gradients during
early Drosophila embryo development.
It was previously reported that Bcd inhibits anterior
Cad synthesis through a direct interaction with eIF4E
(Niessing et al., 2002). This conclusion was based
largely on an in vitro demonstration that Bcd could be
recovered from Drosophila extracts using a cap-affinity
resin, which was prebound to an excess amount of re-
combinant eIF4E. However, under these conditions,
only a small fraction of Bcd was recovered from the
extracts (Niessing et al., 2002). It is therefore a distinct
possibility that Bcd actually bound to the cap-affinity
resin through endogenous d4EHP that was also present
in the extracts. This possibility is consistent with both
the previous data and our present study. Further sup-
porting this conclusion, endogenous deIF4E and Bcd
were not shown to interact in the previous study. Our
data also indicate that the L73R mutation alone is suffi-
cient to explain the previously reported bcdY68A/L73R
double mutant phenotype (Niessing et al., 2002).
Cell
420Proposed d4EHP Mode of Action t
bThe role of 4E-BPs in regulating cap-dependent transla-
tion is well documented (Gingras et al., 1999). 4E-BPs e
minhibit translation by competing with eIF4G for binding
to eIF4E and are therefore general inhibitors of cap- p
hdependent translation, although the degree of inhibition
varies among different mRNAs (Figure 8A). Cup and m
aMaskin are eIF4E binding proteins that regulate transla-
tion during oogenesis and embryonic development (Na- v
kamura et al., 2004; Nelson et al., 2004; Stebbins-Boaz
et al., 1999; Wilhelm et al., 2003). They inhibit the B
rtranslation of specific mRNAs by a simultaneous in-
teraction with eIF4E at the mRNA 5# end and proteins B
ibound to sequence elements in the 3# UTR (Richter and
Sonenberg, 2005). Thus, Cup and Maskin have to com- a
Bpete with eIF4G for binding to eIF4E. While the exact
binding affinities of these proteins for eIF4E have not d
sbeen determined (Nakamura et al., 2004; Nelson et al.,
2004; Stebbins-Boaz et al., 1999; Wilhelm et al., 2003), 5
tit is known that Maskin interacts rather weakly with
eIF4E (Stebbins-Boaz et al., 1999). As a comparison, e
athe 4E-BPs’ affinity for eIF4E (Kd = 15 ± 3 nM) is com-
parable to that of eIF4G (Kd = 27 ± 6 nM) (Marcotrigiano t
met al., 1999).
In contrast to 4E-BP, Cup, and Maskin, Bcd does not d
bneed to compete with eIF4G to interact with d4EHP.
Rather, it is d4EHP that competes with eIF4E for cap o
abinding, which results in translation being inhibited atFigure 8. d4EHP:Bcd Translation Repression Model
(A) By mimicking the eIF4G canonical YxxxxLf eIF4E binding motif, 4E-BP sequesters eIF4E from the initiation complex to inhibit cap-
dependent translation. Phosphorylation of 4E-BP by TOR (Target of Rapamycin; Hay and Sonenberg, 2004) releases it from eIF4E.
(B) In contrast to 4E-BP, Cup, and Maskin, d4EHP binds directly to the cap structure to inhibit translation of a specific mRNA. The simulta-
neous interaction of d4EHP with the mRNA 5# cap structure and Bcd with the BBR renders cad mRNA translationally inactive.he level of cap recognition (Figure 8B). As a result of
ypassing the need to disrupt the very stable eIF4E:
IF4G interaction, d4EHP should interdict translation
ore efficiently than 4E-BPs or other eIF4E binding
roteins. 4EHP-mediated translational regulation may
ave a particularly important role in germline develop-
ent, based on our results and on a recent report that
mutant allele of C. elegans 4EHP (ife-4) shows a se-
ere egg-laying defect (Dinkova et al., 2005).
The delineation of a d4EHP-recognition sequence in
cd (YxxxxxxL) that interacts with d4EHP via its Trp85
esidue highlights the similarities between the d4EHP:
cd interaction and that of eIF4G with eIF4E (YxxxxLf
n eIF4G; Trp73 in eIF4E) (Mader et al., 1995; Marcotrigi-
no et al., 1999). Despite these parallels, the inability of
cd to bind to eIF4E must be explained by structural
ifferences. The presence of two proline residues at po-
ition +3 and +6 of the Bcd d4EHP binding motif (Figure
A) is predicted to significantly alter the α-helical struc-
ure assumed by the YxxxxLf peptide upon binding to
IF4E (Marcotrigiano et al., 1999) and thus prevent Bcd
ssociation with deIF4E. Furthermore, the eIF4E in-
eraction surface of eIF4G is not limited to the YxxxxLf
otif but extends over a larger interface; the N-terminal
omain of eIF4E is also required for folding and tight
inding to eIF4G (Gross et al., 2003). Indeed, the ability
f d4EHP to bind specifically to Bcd, and not to deIF4G
nd d4E-BP (Hernandez et al., 2005), can be explained
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421by the importance of the N-terminal KHPL sequence of
eIF4E in the interaction with eIF4G and 4E-BP (Gross
et al., 2003; Marcotrigiano et al., 1999), since this se-
quence is not conserved in d4EHP (Figure 1C).
Many Different Mechanisms Repress Translation
of Specific mRNAs in the Drosophila Embryo
Our demonstration that cad translation is repressed
through a d4EHP- and Bcd-dependent tethering mech-
anism adds to the diversity of translational control
mechanisms operating in the early Drosophila embryo.
Why are so many translational repression pathways
necessary? If an individual mechanism alone can re-
duce translation of a specific mRNA, but not com-
pletely abrogate it, a combination of inhibitory interac-
tions may be needed in order to accomplish strict
translational control. This can be advantageous if the
diversity of factors, like Bcd, that can confer mRNA
specificity for a given mechanism is relatively limited.
Multiple mRNAs also have to be translationally re-
pressed in overlapping spatial and temporal domains.
Controlling these mRNAs through mechanisms that
target different components of the general translational
machinery, rather than through a common mechanism,
might allow more precise regulation of their individual
expression patterns.
It is noteworthy that although 4EHP is conserved
through evolution, Bcd exists only in higher dipterans
(Lynch and Desplan, 2003). Thus, in other organisms,
4EHP must function during development through pro-
teins that are analogous to Bcd. In summary, we
describe here a novel mode of translational control in
Drosophila development. Because cap-dependent trans-
lation regulation plays such an important role in gene
expression, and since 4EHP is also expressed in so-
matic cells, we predict that examples of d4EHP-
mediated translational repression other than cad are
most likely to exist.
Experimental Procedures
Plasmids
A cDNA coding for d4EHP (SD07020; Research Genetics) was ob-
tained from the Berkeley Drosophila Genome Project (Rubin et al.,
2000). Subcloning and mutagenesis of d4EHP, deIF4EI, and Bcd
were performed using the polymerase chain reaction (PCR). The
PCR-amplified open reading frames, flanked by an EcoRI site in
the 5# and an XhoI site in the 3#, were subcloned into the pcDNA3-
3HA vector (d4EHP and deIF4EI) and the pcDNA3-C-term-FLAG
vector (Bcd). For recombinant protein expression, d4EHP was sub-
cloned into pProEx-His and pGEX6p-1 vectors using BamHI/EcoRI
and EcoRI/XhoI sites, respectively. To create pUASP-d4EHP con-
struct rescue vectors, d4EHP constructs were inserted into the
pUASP vector using KpnI/BamHI restriction sites. The Bcd binding
region (BBR) from cad mRNA was introduced into the 3# UTR of
pcDNA3-rLuc-ApaI reporter vector, either in the sense (BBRsense)
or the antisense (BBRantisense) orientation, using PCR with oligonu-
cleotides containing XbaI sites. To create pCaSpeR4-nos promoter-
Bcd construct-Bcd 3# UTR rescue vectors, Bcd constructs were
inserted into the pKS-nos promoter-X-Bcd 3# UTR vector (X de-
notes a multiple cloning site) using NdeI/BamHI restriction sites.
Subsequently, a KpnI/NotI cassette from the pKS-nos promoter-
Bcd construct-Bcd 3#UTR vectors were transferred into the
pCaSpeR4 vector. All constructs were fully sequenced.
Recombinant Protein Purification
For the purification of GST-d4EHP and His-d4EHP fusion proteins,
E. coli BL21 was transformed with the pGEX6p-d4EHP and thepProEx-His-d4EHP construct. Following a 2 hr induction at 37°C
with 0.1 mM IPTG, the fusion proteins were purified on a Glutathi-
one Sepharose 4B resin (Amersham Pharmacia) and TALON Metal
Affinity resin (BD Bioscience), respectively, according to the manu-
facturer’s instructions.
Anti-d4EHP Antiserum and Western Blotting Analysis
An anti-d4EHP antiserum (#3444) was raised in a New Zealand
white rabbit injected with GST-d4EHP. For Western blotting, pro-
teins were resolved by SDS-PAGE and transferred onto a 0.22 m
nitrocellulose membrane. Membranes were blocked overnight at
4°C with 5% milk in phosphate-buffered saline (PBS) and 0.5%
Tween-20 (PBST). Membranes were incubated for 90 min with one
of the following antibodies: mouse monoclonal anti-HA (Babco;
1:5000), mouse monoclonal anti-FLAG (Sigma; 1:5000), mouse mo-
noclonal anti-His (Qiagen; 1:1000), rabbit polyclonal anti-deIF4E
(1:5000; Sigrist et al., 2000), rabbit polyclonal anti-d4EHP (1:5000),
or mouse monoclonal anti-Bcd (Bcd mab23 ATCC; 1:50). This was
followed by a 1 hr incubation with horseradish peroxidase-coupled
sheep anti-mouse or anti-rabbit (Amersham Pharmacia; 1:5000), or
goat anti-rabbit Fc-specific IgG (Jackson ImmunoResearch;
1:3000). Detection was performed with Western Lightning (Per-
kinElmer).
Cell Culture
Cationic lipid reagent (20 l of Lipofectamine and 30 l of Plus;
Invitrogen) was diluted in serum-free media (Opti-MEM; Invitrogen)
for transfection in Human Embryonic Kidney 293 cells (100 mm
dish). Following a 3 hr incubation, the medium was replaced with
Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen) supple-
mented with 10% Fetal Bovine Serum (FBS). Transfected cells were
harvested in PBS 36 hr following the addition of serum-containing
media. The cells were then lysed by repeated freeze/thaw cycles in
600 l of lysis buffer (20 mM HEPES-KOH [pH 7.6], 200 mM KCl, 0.5
mM EDTA, 10% glycerol, 1% Triton X-100 and Protease Inhibitor
Cocktail [Complete; Roche]) that contains RNase A (50 g/ml). Cell
debris was pelleted by centrifugation, and the protein concentra-
tion in the supernatant was determined using the Bio-Rad assay.
S2 cells were grown at 25°C in Schneider’s Drosophila medium (In-
vitrogen) supplemented with 10% FBS. S2 cell extract and 0–2 hr
embryo extract were prepared as described above.
Cap-Affinity Assay
S2 cell extract (200 l; 8 g/l) was brought up to 1 ml with cap
binding buffer (50 mM Tris-HCl [pH 7.5], 300 mM KCl, 1 mM DTT,
1 mM EDTA, and Protease Inhibitor Cocktail [Complete, Roche]),
and precleared for 1 hr at 4°C with 25 l of Protein A Sepharose.
The supernatant was incubated for 2 hr at 4°C with 25 l of GDP-
sepharose (Sigma) or m7GTP-Sepharose 4B resin (Amersham Phar-
macia). The resin was washed three times with 1 ml of the cap
binding buffer, and the bound proteins were eluted in 2× Laemmli
sample buffer.
Coimmunoprecipitation
For coimmunoprecipitation, 293 cell extract (200 l; 6–10 g/l)
was brought up to 1 ml with the lysis buffer and precleared for 1 hr
at 4°C with 25 l of Protein A Sepharose. The supernatant was
immunoprecipitated for 1 hr at 4°C with 25 l of anti-FLAG M2-
Affinity Gel (Sigma). The resin was washed twice with lysis buffer
and once with lysis buffer containing 300 mM KCl. Immunoprecipi-
tates were eluted in 2× Laemmli sample buffer. For anti-HA, anti-
deIF4E, and anti-d4EHP immunoprecipitations, 25 l of Protein A
Sepharose were preincubated for 2 hr with anti-HA (3 l), anti-
deIF4E (5 l), and anti-d4EHP (5 l). The resin was washed three
times with the lysis buffer prior to immunoprecipitation as de-
scribed above. Embryo extract was used at a concentration of 12
g/l.
P Element Excision and Transgenic Rescue Experiment
Excision experiment was performed as previously described
(Thomson and Lasko, 2004). Transgenic flies were generated by P
element-mediated germline transformation of yw recipients using
pCaSpeR4-nos promoter-Bcd construct-Bcd 3# UTR or pUASP-
Cell
422d4EHP construct vectors. To express d4EHP, the UAS transformant C
Clines were crossed to Act-GAL4 driver line. Transformed bcd and
d4EHP lines were crossed to bcdE1 and d4EHPCP53 mutants, n
respectively, and tested for the rescue of mutant phenotypes. Anti- C
body staining and in situ hybridization were carried out as de- b
scribed (Kobayashi et al., 1999). d4EHP and Cad immunostainings
D
were visualized using AlexaFluor 488 goat anti-rabbit IgG (1:500;
R
Molecular Probes) under confocal laser scanning microscope.
d
t
RT-PCR
DTotal RNA was isolated from embryos using the RNAeasy kit (Qia-
dgen) and then used to analyze various mRNAs by RT-PCR (for
dprimer sequences, see Supplemental Table S2) using the One Step
DRT-PCR kit (Qiagen) according to the manufacturer’s instructions.
p
In Vitro Transcription and Translation Assay D
Plasmids were linearized with ApaI and transcribed using T7 RNA r
polymerase (MBI). Capped mRNA synthesis was performed using G
the RiboMAX system (Promega). Krebs-2 cell extract (12.5 l) was t
incubated for 1 hr at 30°C with 300 ng of capped-mRNA encoding
Gfor individual proteins assayed herein. The extracts were subse-
fquently programmed with 15 ng of the reporter mRNA (capped-
orLuc-BBRsense or capped-rLuc-BBRantisense) and incubated for an
Gadditional hour. Aliquots (2 l) were assayed for luciferase activity
Ausing the Dual-Luciferase reporter assay system (Promega) in a
tLumat LB 9507 bioluminometer (Berthold Technologies). 35S-methi-
aonine labeling was performed as previously described (Brasey et
al., 2003). H
m
H
Supplemental Data r
Supplemental Data include four figures and two tables and can be s
found with this article online at http://www.cell.com/cgi/content/ (
full/121/3/411/DC1/. H
n
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